Getinge AB (publ) (STO:GETI.B)
Sweden · Delayed Price · Currency is SEK 192.30
-1.70 (-0.88%)
Apr 24, 2026, 11:48 AM CET
Revenue Breakdown
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Acute Care Therapies Revenue | 17.91B | 18.68B | 17.95B | ||||||||||||
Acute Care Therapies Revenue Growth | -4.09% | 4.05% | 8.58% | ||||||||||||
Life Science Revenue | 4.55B | 4.50B | 4.55B | ||||||||||||
Life Science Revenue Growth | 1.18% | -1.19% | 5.25% | ||||||||||||
Surgical Workflows Revenue | 11.63B | 11.80B | 12.26B | ||||||||||||
Surgical Workflows Revenue Growth | -1.42% | -3.77% | 11.70% | ||||||||||||
Revenue (Other) | - | - | 1.00M | ||||||||||||
Revenue (Total) | - | 34.97B | 34.76B | ||||||||||||
Revenue (Total) Growth | - | 0.60% | 9.21% |
Revenue by Geography
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Americas Revenue | 15.09B | 15.69B | 15.52B | ||||||||||||
Americas Revenue Growth | -3.79% | 1.10% | 18.03% | ||||||||||||
APAC Revenue | 6.66B | 6.94B | 7.06B | ||||||||||||
APAC Revenue Growth | -4.12% | -1.67% | 1.70% | ||||||||||||
EMEA Revenue | 12.35B | 12.34B | 12.18B | ||||||||||||
EMEA Revenue Growth | 0.04% | 1.30% | 3.77% | ||||||||||||
Revenue (Total) | - | 34.97B | 34.76B | ||||||||||||
Revenue (Total) Growth | - | 0.60% | 9.21% |
Revenue Breakdown 2
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Capital Goods Revenue | 11.57B | 11.97B | 12.42B | ||||||||||||
Capital Goods Revenue Growth | -3.36% | -3.65% | -0.43% | ||||||||||||
Product Sales Recurring Revenue | 15.82B | 16.19B | 15.59B | ||||||||||||
Product Sales Recurring Revenue Growth | -2.23% | 3.83% | 20.26% | ||||||||||||
Service Assignments Incl. Spare Parts Recurring Revenue | 6.70B | 6.82B | 6.75B | ||||||||||||
Service Assignments Incl. Spare Parts Recurring Revenue Growth | -1.64% | 0.96% | 5.62% | ||||||||||||
Total Recurring Revenue | 22.53B | 23.00B | 22.34B | ||||||||||||
Total Recurring Revenue Growth | -2.06% | 2.97% | 15.42% | ||||||||||||
Revenue (Total) | - | 34.97B | 34.76B | ||||||||||||
Revenue (Total) Growth | - | 0.60% | 9.21% |
Gross Profit
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Acute Care Therapies Gross Profit | 9.96B | 10.42B | 9.62B | ||||||||||||
Acute Care Therapies Gross Profit Growth | -4.45% | 8.37% | 6.49% | ||||||||||||
Life Science Gross Profit | 1.56B | 1.56B | 1.70B | ||||||||||||
Life Science Gross Profit Growth | 0.32% | -8.25% | 18.52% | ||||||||||||
Surgical Workflows Gross Profit | 4.65B | 4.68B | 4.84B | ||||||||||||
Surgical Workflows Gross Profit Growth | -0.62% | -3.37% | 20.00% | ||||||||||||
Gross Profit (Other) | - | -1.00M | - | ||||||||||||
Gross Profit (Total) | - | 16.65B | 16.15B | ||||||||||||
Gross Profit (Total) Growth | - | 3.10% | 11.44% |
EBIT
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Acute Care Therapies Operating Profit | 3.03B | 3.02B | 2.07B | ||||||||||||
Acute Care Therapies Operating Profit Growth | 0.36% | 46.29% | -35.77% | ||||||||||||
Life Science Operating Profit | 511.00M | 470.00M | 526.00M | ||||||||||||
Life Science Operating Profit Growth | 8.72% | -10.65% | 33.16% | ||||||||||||
Surgical Workflows Operating Profit | 846.00M | 773.00M | 703.00M | ||||||||||||
Surgical Workflows Operating Profit Growth | 9.44% | 9.96% | 4.15% | ||||||||||||
Group Functions and Other Items Operating Profit | -490.00M | -474.00M | -440.00M | ||||||||||||
Operating Income (Other) | - | -1.00M | - | ||||||||||||
Operating Income (Total) | - | 3.79B | 2.85B | ||||||||||||
Operating Income (Total) Growth | - | 32.76% | -23.61% |
Adjusted EBITDA
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Acute Care Therapies Adjusted EBITA | 3.51B | 3.76B | 3.55B | ||||||||||||
Acute Care Therapies Adjusted EBITA Growth | -6.62% | 5.88% | 14.02% | ||||||||||||
Life Science Revenue Adjusted EBITA | 532.00M | 490.00M | 608.00M | ||||||||||||
Life Science Revenue Adjusted EBITA Growth | 8.57% | -19.41% | 41.39% | ||||||||||||
Surgical Workflows Adjusted EBITA | 1.10B | 1.08B | 1.09B | ||||||||||||
Surgical Workflows Adjusted EBITA Growth | 2.41% | -1.19% | 51.18% | ||||||||||||
Group Functions and Other Items Adjusted EBITA | -450.00M | -450.00M | -383.00M | ||||||||||||
Operating Income (Other) | - | -1.09B | -2.02B | ||||||||||||
Operating Income (Total) | - | 3.79B | 2.85B | ||||||||||||
Operating Income (Total) Growth | - | 32.76% | -23.61% |
Key Performance Indicators
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Acute Care Therapies - Order Intake | 17.55B | 18.22B | 17.72B | ||||||||||||
Acute Care Therapies - Order Intake Growth | -3.67% | 2.83% | 8.21% | ||||||||||||
Life Science - Order Intake | 4.18B | 4.25B | 4.60B | ||||||||||||
Life Science - Order Intake Growth | -1.65% | -7.58% | 10.92% | ||||||||||||
Surgical Workflows - Order Intake | 11.60B | 11.55B | 11.91B | ||||||||||||
Surgical Workflows - Order Intake Growth | 0.37% | -3.01% | 14.86% | ||||||||||||
Total Order Intake | 33.33B | 34.03B | 34.23B | ||||||||||||
Total Order Intake Growth | -2.04% | -0.60% | 10.80% | ||||||||||||
Order Intake - Organic Growth | - | 3.50% | 6.30% | ||||||||||||
Acute Care Therapies Net Sales - Organic Growth | - | 7.00% | 8.20% | ||||||||||||
Life Science Net Sales - Organic Growth | - | 4.10% | -1.90% | ||||||||||||
Surgical Workflows Net Sales - Organic Growth | - | 2.10% | 2.60% | ||||||||||||
Total Net Sales Organic Growth | - | 4.90% | 4.90% |
Updated Mar 31, 2026. Data Source: Fiscal.ai.